Veracyte
Local Coverage Determinations Roundup: Scipher Medicine, Veracyte, Sonic Healthcare USA
A roundup of local coverage determinations from Medicare administrative contractors.
Duke Researchers Use Veracyte Data to ID Prostate Cancer Subgroups for Added Post-Surgery Treatment
Premium
The recent JCO Precision Oncology study could bolster the research use case for Veracyte's Decipher GRID database in better defining prostate cancer subgroups.
Top Five Articles on 360Dx Last Week: Veracyte Q2 Results; Egoo Prepares for US Entry; and More
Last week, readers were most interested in an update on Veracyte's business, including its legacy tests, which drove revenue growth in the second quarter.
Veracyte Prostate, Thyroid Cancer Tests Drive Q2 Growth as Firm Eyes Milestones for Newer Assays
Premium
The company performed nearly 32,000 tests during the quarter, a 28 percent increase over the same period of 2022, with Decipher and Afirma assays driving the growth.
Veracyte Q1 Revenues up 22 Percent as Firm Beats Analyst Estimates
The company's testing revenues rose 29 percent in Q1 thanks to increased adoption of its Decipher Prostate and Afirma tests.
Apr 3, 2023
Sep 1, 2022
360Dx Top 30 Tumbles in August
May 4, 2022
May 3, 2022
Veracyte Q1 Revenues Jump 85 Percent
Feb 28, 2022
Veracyte Revenues Almost Double in Q4
Nov 9, 2021
Veracyte Q3 Revenues Nearly Double
Oct 28, 2021
Jun 4, 2021
Jun 1, 2021